← Open Payments lookup

SHERWIN WONG: Open Payments

NPI 1548920010 · VALENCIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$771 in 22 payments from 7 companies in 2025. Trend: 2023 $525 · 2024 $796 · 2025 $771

Food & beverage: $771
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$397
Vanda Pharmaceuticals Inc.4$192
Teva Pharmaceuticals USA, Inc.3$62
ABBVIE INC.2$43
Otsuka America Pharmaceutical, Inc.1$29
E.R. Squibb & Sons, L.L.C.1$28
Supernus Pharmaceuticals, Inc.1$20

Products named: CAPLYTA, FANAPT, AUSTEDO XR, VRAYLAR, REXULTI, COBENFY, Qelbree.

Industry payments across CA — which companies pay providers there.